ASCO2023 is in full swing, and our docs are learning from and presenting information to physicians from across the globe about cancer care!
West Radiation Oncologist, Dr. Matthew Ballo, shared his hands-on experience in the utilization of Tumor Treating Fields against glioblastoma.
Ballo, alongside several fellow physicians, authored a poster presented at ASCO (American Society of Clinical Oncology Conference ’23) that suggests a significant survival benefit with TTFields therapy added to standard radio-chemotherapy for patients with newly diagnosed glioblastoma (GBM), and that a 75% usage rate maybe meaningful in the real-world setting, with research sponsor Novocure, Optune Support For Glioblastoma.